Briefing: Lack of FDA Advisory Committees Raises Concerns

Summary

• FDA is reportedly shunning advisory committees.
• Concerns from drugmakers, patients, and doctors.
• Potential implications for drug approval processes.

Key Facts

Fact	Value
Source	STAT
Published Date	March 9, 2026

Sources

• STAT: https://www.statnews.com/pharmalot/2026/03/09/fda-biosimilars-prasad-novo-hims-weight-wegovy/?utm_campaign=rss